NCT04003636 2026-03-24KEYNOTE-966Merck Sharp & Dohme LLCPhase 3 Completed1,069 enrolled 19 charts 2 FDA
NCT04430738 2026-02-24Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal CancersSeagen Inc.Phase 2 Active not recruiting40 enrolled 67 charts
NCT04383210 2025-04-03Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid TumorsElevation OncologyPhase 2 Terminated54 enrolled 11 charts
NCT04066491 2023-11-14Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L BTCEMD SeronoPhase 2/3 Terminated309 enrolled 17 charts
NCT03833661 2023-10-25M7824 Monotherapy in Locally Advanced or Metastatic Second Line (2L) Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer)EMD SeronoPhase 2 Completed159 enrolled 23 charts
NCT00538850 2014-03-05Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainINSYS Therapeutics IncPhase 3 Completed130 enrolled 9 charts